Definitive Contract W911SR25C0013

This is a $1,099,949.64 firm fixed-price Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army's Research, Development and Engineering Command (RDECOM) to CFD Research Corporation, a small engineering and technology firm based in Huntsville, Alabama. The contract is for the development of a new broad-spectrum antiviral drug against viruses from the Bunyaviral family. This SBIR Phase II award builds upon prior Phase I research and will support further development of...

<p>This is a $161,589.36 firm fixed price Purchase Order issued by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Extend Biosciences Inc., a woman-owned small business. The contract is for an Army Small Business Innovation Research (SBIR) Phase I project, which is a set-aside for small businesses. The contract was awarded on March 13, 2020 and has a completion date of September 13, 2020. The place of performance is Newton, MA 02458.</p>

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract to CFD Research Corporation, a for-profit organization, to perform Phase I SBIR research on a &quot;SMART BIOREACTOR FOR LARGE-SCALE HIGH TITER PHAGE PREPS&quot; project. The contract has a potential value of $299,946.26 and a completion date of August 15, 2022. This SBIR award was not set aside for a specific business...

This is a $526,793.52 Firm Fixed Price SBIR Phase II contract awarded by the Joint PEO Chemical and Biological Defense to Arisan Therapeutics Inc., a small disadvantaged business. The contract is for research and development services supporting the development of countermeasures against chemical and biological threats. This contract is a follow-on to previous SBIR Phase I and II awards to Arisan Therapeutics totaling over $790,000. The company has also received other federal research contracts...

The Department of the Army Materiel Command Research Development and Engineering Command awarded a Small Business Set Aside contract to Chimerocyte, Inc. for a Phase I STTR (Small Business Technology Transfer) research project. The contract, valued at $166,498.47, was awarded on December 7, 2020 and is scheduled for completion on June 6, 2021. The contract was issued in response to the Coronavirus COVID-19 National Interest Action code, indicating this research project is related to pandemic...

This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the Joint Program Executive Office for Chemical and Biological Defense, a Department of Defense agency, to Bioo Scientific Corporation, a subsidiary of Revvity Inc. The $116,638.65 firm-fixed-price contract supports research and development work related to the SBIR program. The contract was awarded on June 14, 2016, with a completion date of June 13, 2017. As an SBIR Phase I contract, this award supports...

This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Chimerocyte, Inc., a for-profit organization. The contract, valued at $1,092,350.01, is for the development of &quot;Iodide for the Treatment of Influenza and Other Stresses&quot; under a Firm Fixed Price agreement. The contract has a period of performance through September 29, 2024. This SBIR Phase II award builds upon a previous SBIR Phase I...

The Defense Health Agency awarded a $249,956.88 Small Business Innovation Research Phase 1 contract to Firebird Biomolecular Sciences LLC for the development of &quot;Innovative DNA for Highly Multiplexed Molecular Diagnostics.&quot; The firm-fixed-price purchase order, set aside for small businesses, was awarded on October 9, 2024, with performance completion targeted for May 8, 2025. Firebird Biomolecular Sciences LLC, a small business specializing in advanced molecular diagnostics and...

This is a Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of point-of-care technologies to monitor and characterize host-pathogen interactions during acute severe infection. The contract has a ceiling value of $147,130.17 and an ultimate completion date of November 24, 2017. The contract is set aside for small...

This is a $799,999.76 Firm Fixed Price contract awarded by the Joint PEO Chemical and Biological Defense, a Defense agency, to Bioo Scientific Corporation, a small business manufacturer. The contract is designated as a Small Business Innovation Research (SBIR) Program Phase II Action, indicating it is a follow-on award to further develop a technology or product initially funded under a Phase I SBIR award. Bioo Scientific Corporation is a subsidiary of the parent company Revvity Inc., which has a...